In vitro activity of Daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains

被引：34

作者：

Diederen, Bram M. W.

van Duijn, Inge

Willemse, Piet

Kluytmans, Jan A. J. W.

机构：

[1] St Elizabeth Hosp, Lab Med Microbiol, NL-5000 AS Tilburg, Netherlands

[2] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2006年 / 50卷 / 09期

关键词：

D O I：

10.1128/AAC.00526-06

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The purpose of the present study was to assess the in vitro activity of daptomycin against a well-defined collection of methicillin-resistant Staphylococcus aureus (MRSA) isolates (n = 98), including heterogeneously glycopeptide-resistant MRSA (hGISA) strains. Susceptibility testing was performed by using the Etest system. Daptomycin was potent against both glycopeptide-susceptible and hGISA strains.

引用

收藏

页码：3189 / 3191

页数：3

相关论文

共 21 条

[1] Staphylococcus aureus:: A well-armed pathogen [J].

Archer, GL .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) :1179-1181

[2] In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers [J].

Barry, AL ;

Fuchs, PC ;

Brown, SD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1919-1922

[3] National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].

Cardo, D ;

Horan, T ;

Andrus, M ;

Dembinski, M ;

Edwards, J ;

Peavy, G ;

Tolson, J ;

Wagner, D .

AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485

[4] Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogens [J].

Carpenter, CF ;

Chambers, HF .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (07) :994-1000

[5] Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene [J].

Chang, S ;

Sievert, DM ;

Hageman, JC ;

Boulton, ML ;

Tenover, FC ;

Downes, FP ;

Shah, S ;

Rudrik, JT ;

Pupp, GR ;

Brown, WJ ;

Cardo, D ;

Fridkin, SK .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1342-1347

[6] The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes:: Mortality, length of stay, and hospital charges [J].

Cosgrove, SE ;

Qi, YL ;

Kaye, KS ;

Harbarth, S ;

Karchmer, AW ;

Carmeli, Y .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (02) :166-174

[7] Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus [J].

Cui, LZ ;

Tominaga, E ;

Neoh, HM ;

Hiramatsu, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :1079-1082

[8] In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants [J].

Fluit, AC ;

Schmitz, FJ ;

Verhoef, J ;

Milatovic, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (03) :1007-1011

[9] In vitro bactericidal activity of daptomycin against staphylococci [J].

Fuchs, PC ;

Barry, AL ;

Brown, SD .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) :467-470

[10] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].

Hiramatsu, K ;

Hanaki, H ;

Ino, T ;

Yabuta, K ;

Oguri, T ;

Tenover, FC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136